STEPHAN QUENTZEL: Open Payments
NPI 1699817080 · NEW YORK CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,718 in 43 payments from 8 companies in 2025. Trend: 2023 $27,404 · 2024 $15,102 · 2025 $6,718
Speaker / faculty: $5,500Food & beverage: $1,053Travel & lodging: $165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $6,067 |
| Alkermes, Inc. | 7 | $170 |
| Bausch Health US, LLC | 6 | $137 |
| Supernus Pharmaceuticals, Inc. | 4 | $109 |
| Axsome Therapeutics, Inc. | 1 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
| Lundbeck LLC | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
Products named: VRAYLAR, APLENZIN, LYBALVI, Qelbree, Auvelity, TRINTELLIX, REXULTI, ARISTADA.
Industry payments across NY — which companies pay providers there.
